Globus Medical (GMED) PT Lowered to $100 at KeyBanc
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Price: $80.08 +1.12%
Rating Summary:
22 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 23
Rating Summary:
22 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 23
Join SI Premium – FREE
KeyBanc lowered its price target on Globus Medical (NYSE: GMED) to $100.00 (from $115.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Take-Two Interactive (TTWO) PT Raised to $368 at BofA Securities
- Corbus Pharmaceuticals (CRBP) PT Lowered to $34 at Mizuho
- Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
